Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Starch
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : Purdue University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses
Details : Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 11, 2014
Lead Product(s) : Starch
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : Purdue University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : SC-FOS
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Recipient : NIZO Food Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults
Details : SC-FOS is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 16, 2014
Lead Product(s) : SC-FOS
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Recipient : NIZO Food Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Dietary Fiber on Insulin Sensitivity
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 31, 2012
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Dietary Fiber on Fecal Microbiota and Metabolism
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 25, 2012
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessing Fermentability of a Dietary Fiber
Details : Dietary Fiber is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 22, 2011
Lead Product(s) : Dietary Fiber
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Starch
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Types of Resistant Starch and Their Effect on Appetite
Details : Starch is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 19, 2010
Lead Product(s) : Starch
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Clinical Nutrition Research Center, Illinois Institute of Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
